Shandong Weigao Group Medical Polymer Company Limited
Research Shandong Weigao Group Medical Polymer Company Limited (1066.HK) on Bullrun: market cap HKD 15.01B, P/E 10.1, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1066.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyHKD
- Market capHKD 15.01B
- P/E10.1
- Dividend yield2.1%
- Financial periodFY2025
- RevenueCNY 13.39B
- Revenue growth2.3%
- Net incomeCNY 1.61B
- Free cash flowCNY 1.72B
- Gross margin47.6%
Valuation Snapshot
latest market cap is HKD 15.01B; P/E is 10.1; dividend yield is 2.1%.
Peer valuation comparison
Latest P/E is 10.14x versus a Healthcare sector median of 21.69x (53.3% below).
Latest dividend yield is 2.05% versus a Healthcare sector median of 2.41% (14.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 13.39B | CNY 1.61B | CNY 1.72B | 47.6% | 0.35 | CNY 8.57B | CNY 5.10B | CNY 24.11B |
| FY2024 | CNY 13.09B | CNY 2.07B | CNY 2.14B | 50.3% | 0.45 | CNY 7.78B | CNY 4.19B | CNY 23.75B |
| FY2023 | CNY 13.23B | CNY 2.00B | CNY 2.11B | 50.2% | 0.44 | CNY 6.99B | CNY 4.17B | CNY 22.45B |
| FY2022 | CNY 13.75B | CNY 2.76B | CNY 1.18B | 53.1% | 0.61 | CNY 6.96B | CNY 4.49B | CNY 21.77B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 15.01B | 10.1 | 5.2% | 0.17 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.17 HKD, yield 2.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.24 CNY |
| FY2024 | 0.2 CNY |
| FY2023 | 0.17 CNY |
| FY2022 | 0.17 CNY |
| FY2021 | 0.18 CNY |
About Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shandong Weigao Group Medical Polymer Company Limited's market cap?
Shandong Weigao Group Medical Polymer Company Limited's market capitalization is HKD 15.01B.
What is Shandong Weigao Group Medical Polymer Company Limited's P/E ratio?
Shandong Weigao Group Medical Polymer Company Limited's price-to-earnings (P/E) ratio is 10.1.
Does Shandong Weigao Group Medical Polymer Company Limited pay a dividend?
Shandong Weigao Group Medical Polymer Company Limited has a dividend yield of 2.1%.
What does Shandong Weigao Group Medical Polymer Company Limited do?
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments.